Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FP.2.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FP.2.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.2.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.571ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.571ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.571ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.571NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.55 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.55 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.55 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.55 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAMNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.239ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.239ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.239ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.239NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.574ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.574ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.574ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.574NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.355ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.355ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.355ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.355NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.7.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.7.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used